Efficacy and Safety of Trastuzumab Combined with Pertuzumab for Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer: A Meta-Analysis Study of Randomized Control Trials

Figure 4

Meta-analysis of the incidence of gastrointestinal adverse reactions after treatment in the two groups of patients. (a) Forest plot of diarrhea. (b) Forest plot of nausea. (c) Forest plot of vomiting. (d) Forest plot of constipation.

(a)

(b)

(c)

(d)